Radiation therapy treatment characteristics of the pre-intervention cohort
| Treatment characteristics | |
| EBRT | Median (range) |
| Dose (Gy) | 45 (45–45.5) |
| # of fractions | 25 (25–26) |
| EBRT field | N (%) |
| WP | 14 (58.3%) |
| EFRT | 10 (41.7%) |
| EBRT modality | N (%) |
| IMRT | 21 (87.5%) |
| 3D-CRT | 3 (12.5%) |
| Location of EBRT | N (%) |
| University campus | 20 (83.3%) |
| University affiliates | 2 (8.3%) |
| Outside institutions | 2 (8.3%) |
| Brachytherapy | Median (range) |
| Dose (Gy) | 27.5 (21–30) |
| Fractions (T&R only) | 5 (5–6) |
| Brachytherapy modality | N (%) |
| T&R | 17 (70.8%) |
| Interstitial | 7 (29.2%) |
| Parametrial boost | Median (range) |
| Dose (Gy) | 5.4 (5–10.8) |
| # of fractions | 3 (2–5) |
| # boosted | 21 (87.5%) |
| No boost | 3 (12.5%) |
RT treatment characteristics for the initial cohort of 24 patients treated with definitive CRT.
CRT, chemoradiation; 3D-CRT, three-dimensional conformal radiation therapy; EBRT, external beam radiation therapy; EFRT, extended field radiation therapy; IMRT, intensity-modulated radiation therapy; RT, radiation therapy; T&R, tandem and ring; WP, whole pelvis.